drugset / Trial / NCT04151758

Effect of Docosahexaenoic Acid Supplementation on Microbiome in Obese ChiLdrEn.

NCT04151758

Phase 4 Unknown 30 enrolled University of Milan
NaSingle-groupOpen-labelTreatment

Summary

Evaluation of the possible effect of DHA supplementation, combined with interventions aimed at improving diet and lifestyle, on gut microbiota composition and metabolite production.

Timeline

Start
2019-01-07
Primary completion
2021-05-30
Completion
2021-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject DOCONEXENT Other / unclassified 500 mg

Indications

No indication recorded.